Profile: Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

803.50INR
24 Dec 2014
Price Change (% chg)

Rs-9.80 (-1.20%)
Prev Close
Rs813.30
Open
Rs812.05
Day's High
Rs816.00
Day's Low
Rs800.00
Volume
3,936,246
Avg. Vol
2,447,561
52-wk High
Rs932.50
52-wk Low
Rs552.55

Search Stocks
Sun Pharmaceutical Industries Limited is an international specialty pharma company. The Company manufactures and markets pharmaceutical formulations as branded generics, as well as generics in India, the United states and several other markets across the world. The Company’s business is divided into four segments: US Generics, Indian Branded Generics, International Branded Generics (Rest of the world, except the US and India) and Active Pharmaceutical Ingredients (API). Its brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. It makes specialty APIs, including peptides, steroids, hormones and anticancers. The Company manufactures 170 APIs. It’s API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol. In July 2014, Sun Pharmaceutical Industries Ltd acquired Pharmalucence Inc.

Company Address

Sun Pharmaceutical Industries Ltd

Acme Plaza
Andheri - Kurla Rd, Andheri (E)
Andheri (East)
MUMBAI     400059
P: +9122.66969696
F: +9122.28212010

Company Web Links

Search Stocks